Some protocols utilize 2 mg doses administered 2-3 times per week as an alternative approach that reduces injection frequency while maintaining effectiveness
Aging-related growth hormone (GH) decrease is a selective hypothalamic GH-releasing hormone pulse amplitude mediated phenomenon
Ingredients Hippophae Rhamnoides Water, Glycerin, Dipropylene Glycol, Propanediol, Niacinamide, 1-2-Hexanediol, Caprylic-Capric Triglyceride, Water, PPG-13-Decyl Tetradeses-24, Hydroxyacetophenone, Caprylyl Glycol, Hydrogenated Lecithin, Carbomer, Glutathione, Tromethamine, Cetearyl Alcohol, Disodium EDTA, Stearic Acid, Dipotassium Glycyrrhizate, Terminalia Ferdinandiana Fruit Extract, Butylene Glycol, Lecithin, Pentylene Glycol, Acetyl Glutamine, Sodium Hyaluronate, Folic Acid, Bacillus-Soybean Ferment Extract, Oligopeptide-1, Hexapeptide-11, Oligopeptide-2, Oligopeptide-3, Hydrolyzed Pea Protein, Madecassoside, Phytosterols, Squalane, Olea Europaea (Olive) Fruit Oil, Tocopherol, Polyglyceryl-10 Stearate, Panthenol, Hyaluronic Acid, Hydrolyzed Hyaluronic Acid, Hydroxypropyltrimonium Hyaluronate, Hydrolyzed Sodium Hyaluronate, Potassium Hyaluronate, Ceramide NP, Sodium Ascorbyl Phosphate, Butyrospermum Parkii (Shea Butter), Ethylhexylglycerin, Sodium Hyaluronate Crosspolymer, Biotin, Pyridoxine, Cyanocobalamin, Riboflavin, Thiamine HCl, Retinol, Bioflavonoids, Sodium Acetylated Hyaluronate, Menadione, Acetyl Hexapeptide-8, Copper Tripeptide-1, Palmitoyl Pentapeptide-4, Linoleic Acid, Beta-Carotene, Fragrance The manufacturer is responsible for the products ingredients
The main focus of FOXO4-DRI peptide research is focused on its potential to prevent the binding of the FOXO4 protein with p53 protein
